SACHA DEGRAFFENREID-YATES: Open Payments
NPI 1275088437 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,336 in 129 payments from 17 companies in 2025. Trend: 2023 $1,199 · 2024 $2,005 · 2025 $2,336
Food & beverage: $2,243Education: $93
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 33 | $403 |
| UCB, Inc. | 18 | $323 |
| GlaxoSmithKline, LLC. | 19 | $318 |
| PFIZER INC. | 12 | $230 |
| E.R. Squibb & Sons, L.L.C. | 9 | $198 |
| AstraZeneca Pharmaceuticals LP | 7 | $167 |
| Novartis Pharmaceuticals Corporation | 8 | $152 |
| GENZYME CORPORATION | 6 | $144 |
| CSL Behring | 4 | $82 |
| ABBVIE INC. | 3 | $78 |
Products named: Bimzelx, DUPIXENT, ORENCIA, XELJANZ, BENLYSTA, OTEZLA, NUCALA, COSENTYX.
Industry payments across MO — which companies pay providers there.
